Cell-free Bioprocessing is an unprecedented flexible bio-manufacturing platform that preserves the cell's inherent manufacturing capabilities while eliminating the cumbersome need to keep the host organism alive.
GreenLight is creating a portfolio of important families of molecules and partnering with industry to help bring that innovation to the world.
Essential fatty acids
Ribose and ribose derivatives
Pyrimidines and pyrimidines derivatives
Antimetabolites for HIV, HCS, and Cancer Therapies
Our aim is to significantly improve human health and protect the environment by ensuring an ample supply of clean, affordable, healthy foods and supplements; creating new, effective medicines; and enabling the low-cost conversion of natural gas to liquid fuel.
GreenLight's strategic partnerships are key to help take our innovation to market faster.
In collaboration with industrial partners and the US government, GreenLight is developing specific Cell-free Bioprocessing pathways for important compounds in the following areas:
Novel and efficient production of a central nervous system API
Sustainable production of food ingredients
Novel production of bio-insecticides respectful with the environment
Novel production of methane into chemicals (ARPA-e)
GreenLight is researching novel Cell-free Bioprocessing production approaches for three new families of molecules and reaching out to industry for partners for development and commercialization.
Anti-metabolites for HIV, HCV, and anti cancer applications
Rare sugars, Ribose, and Ribose derivatives
High Purity Fatty Acids